The Unexplored 5q13 Locus: A Role in Hematopoietic Malignancies

References

• Estey E.H., Keating M.J., Dixon D.O., Trujillo J.M., McCredie K.B., Freireich E.J. Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia. Hematologic Pathology 1987; 1: 203–208
   PubMedGoogle Scholar
• Keating M.J., Cork A., Broach Y., Smith T., Walters R.S., McCredie K.B., Trujillo J., Freireich E.J. Towards a clinically relevant cytogenetic classification of acute myelogenous leukemia. Leukemia Research 1987; 11: 119–133
   PubMed Web of Science ®Google Scholar
• Kinsler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87(2)159–170
   PubMed Web of Science ®Google Scholar
• Mitelman F. Chromosome 5. Catalog of Chromosome Aberrations in Cancer, Fifth Edition, F. Mitelman. Wiley-Liss, New York 1994; 681–837
   Google Scholar
• Le Beau M.M., Espinosa R., III, Neuman W.L., Stock W., Roulston D., Larson R.A., Keinanen M., Westbrook C.A. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proceedings of the National Academy of Science USA 1993; 90: 5484–5488
   PubMed Web of Science ®Google Scholar
• Boultwood J., Fidler C., Lewis S., Kelly S., Sheridan H., Littlewood T.J., Buckle V.J., Wainscoat J.S. Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint. Genomics 1994; 19: 425–432
   PubMed Web of Science ®Google Scholar
• Nagarajan L., Zavadil J., Claxton D., Lu X., Fairman J., Warrington J.A., Wasmuth J.J., Chinault A.C., Sever C.E., Slovak M.L., Willman C.L., Deisseroth A.B. Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q- chromosome. Blood 1994; 83: 199–208
   PubMed Web of Science ®Google Scholar
• Fairman J., Chumakov I., Chinault A.C., Nowell P.C., Nagarajan L. Physical mapping of the minimal region of loss in 5q- chromosome. Proceedings of the National Academy of Science USA 1995; 92: 7406–7410
   PubMed Web of Science ®Google Scholar
• Fairman J., Wang R.Y., Liang H., Zhao L., Saltman D., Liang J.C., Nagarajan L. Translocations and deletions of 5q13.1 in myelodysplasia and acute myelogenous leukemia: evidence for a novel critical locus. Blood 1996; 88: 2259–2266
   PubMed Web of Science ®Google Scholar
• Horrigan S.K., Westbrook C.A., Kim A.H., Banerjee M., Stock W., Larson R.A. Polymerase chain reaction-based diagnosis of del(5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval. Blood 1996; 88(7)2665–2670
   PubMed Web of Science ®Google Scholar
• Zhou N., Stoffei A., Wang P.W., Eisenbart J.D., Espinosa R., Larson R.A., LeBeau M.M. Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map. Proceedings of the National Academy of Science USA 1997; 94: 6948–6953
   PubMed Web of Science ®Google Scholar
• Pedersen B., Jensen I.M. Clinical and prognostic implications of chromosome 5q deletions: 96 high resolution studied patients. Leukemia 1991; 5: 566–573
   PubMed Web of Science ®Google Scholar
• Pedersen B. Anatomy of the 5q- deletion: different sex ratios and deleted 5q bands in MDS and AML. Leukemia 1996; 10: 1883–1890
   PubMed Web of Science ®Google Scholar
• Gogineni S.K., da Costa M., Verma R.S. A new translocation, t(5;21)(q13;q22) in acute myelogenous leukemia. Cancer Genetics Cytogenetics 1996; 88: 167–169
   PubMed Web of Science ®Google Scholar
• Mitelman F., Nilsson P.G., Brandt L., Alimena G., Gastaldi R., Dallapiccola B. Chromosome pattern, occupation, and clinical features in patients with acute nonlympho-cytic leukemia. Cancer Genetics Cytogenetics 1981; 4: 197–214
   PubMed Web of Science ®Google Scholar
• Roulston D., Nucifora G., Dietz-Band J., Lebeau M.M., Rowley J.D. Detection of rare 21q22 translocation breakpoints within the AML1 gene in myeloid neoplasms by fluorescence in situ hybridization. Blood 1993; 82: 532a
   Web of Science ®Google Scholar
• Kobayashi H., Montgomery K.T., Bohlander S.K., Adra C.N., Lim B.L., Kucherlapati R.S., Donis-Keller H., Le Beau M.M., Rowley J.D. Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases. Blood 1994; 84(10)3473–3482
   PubMed Web of Science ®Google Scholar
• Haglund U., Juliusson G., Stellan B., Gahrton G. Hairy cell leukemia is characterized by clonal chromosome abnormalities clustered to specific regions. Blood 1994; 83: 2637–2645
   PubMed Web of Science ®Google Scholar
• Whelan A.J., Watson M.S., Porter F.D., Steiner R.D. Klippel-Trenaunay-Weber syndrome associated with a 5:11 balanced translocation. American Journal of Medical Genetics 1995; 59: 492–A94
   PubMed Web of Science ®Google Scholar
• Chen Z., Rodman M., Stone J.F., Sandberg A.A. Identification of complex t(15;17) in APL by FISH. Cancer Genetics Cytogenetics 1994; 72: 73–74
   PubMed Web of Science ®Google Scholar
• Hirata J., Umemura T., Nishimura J., Sadamura S., Sato H., Nawata H. Double t(1;7)(p36;p11) in a megakaryocytic crisis of chronic myelogenous leukemia with variant t(5;9;22). Cancer Genetics Cytogenetics 1992; 65: 107–110
   Web of Science ®Google Scholar
• Lai J-L., Preudhomme C., Zandecki M., Flactif M., Vanrumbeke M., Lepelley P., Wattel E., Fenaux P. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoiesis and a high incidence of p53 mutations. Leukemia 1995; 9: 370–381
   PubMed Web of Science ®Google Scholar
• Simonic I., Gericke G.S. The enigma of common fragile sites. Human Genetics 1996; 97: 524–531
   PubMed Web of Science ®Google Scholar
• Yunis J.J., Soreng A.L. Constitutive fragile sites and cancer. Science 1984; 226: 1199–1204
   PubMed Web of Science ®Google Scholar
• Jones C., Penny L., Mattina T., Yu S., Baker E., Voullaire L., Langdon W.Y., Sutherland G.R., Richards R.I., Tunnacliffe A. Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2. Nature 1995; 376: 145–149
   PubMed Web of Science ®Google Scholar
• Van den Berghe H., Vermaelen K., Mecucci C., Barbieri D., Tricot G. The 5q- anomaly. Cancer Genetics Cytogenetics 1985; 17: 89–255
   Web of Science ®Google Scholar
• Tavassoli M., Steingrimsdottir H., Pierce E., Jiang X., Alagox M., Farzaneh F., Campbell I.G. Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21. British Journal of Cancer 1996; 74(1)115–119
   PubMed Web of Science ®Google Scholar
• Cunningham J.M., Shan A., Wick M.J., McDonnell S.K., Schaid D.J., Tester D.J., Qian J., Takahaski S., Jenkins R.B., Bostwick D.G., Thibodeau S.N. Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Research 1996; 56: 4475–4482
   PubMed Web of Science ®Google Scholar
• Wieland I., Bohm M., Arden K.C., Ammermuller T., Bogatz S., Viars C.S., Rajewsky M.F. Allelic deletion mapping on chromosome 5 in human carcinomas. Oncogene 1996; 12(1)97–102
   PubMed Web of Science ®Google Scholar
• Tamura G., Ogasawara S., Nishizuka S., Sakata K., Maesawa C., Suzuki Y., Terashima M., Saito K., Satodate R. Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach. Cancer Research 1996; 56: 612–615
   PubMed Web of Science ®Google Scholar
• McCallum S.J., Wu W.J., Cerione R.A. Identification of a putative effector for Cdc42Hs with high sequence similarity to the RasGAP-related protein IQGAP1 and a Cdc42Hs binding partner with similarity to IQGAP2. Journal of Biological Chemistry 1996; 271(36)21732–21737
   PubMed Web of Science ®Google Scholar
• Otevrel T., Stamato T.D. Regional localization of the XRCC4 human radiation repair gene. Genomics 1995; 27(1)211–214
   PubMed Web of Science ®Google Scholar
• Hobson G.M., Krahe R., García E., Siciliano M.J., Funanage V.L. Regional chromosomal assignments for four members of the MADS domain transcription enhancer factor 2 (MEF2) gene family to human chromosomes 15q26, 19p12, 5q14, and Iq12-q23. Genomics, 29(3)704–711
   PubMed Web of Science ®Google Scholar
• Mitsudomi T., Friedman E., Gejman P.V., McCormick F., Gazdar A.F. Genetic analysis of the catalytic domain of the GAP gene in human lung cancer cell lines. Human Genetics 1994; 93: 27–31
   PubMed Web of Science ®Google Scholar